CLINICAL EXAMPLES OF ANTICYTOKINE TREATMENT OF CHILDREN WITH CROHN DISEASE
Abstract
Key words: Crohn’s disease, children, anticytokine therapy, infliximab.
(Voprosy sovremennoi pediatrii — Current Pediatrics. — 2011; 10 (5): 74–80.)
About the Authors
M.M. VenediktovaE.G. Tsimbalova
А.S. Potapov
References
1. Мазанкова Л.Н., Халиф И.Л., Водилова О.В. Болезнь Крона у детей. Принципы диагностики и лечения. М.: МЕДпресс–информ. 2008.
2. Sartor R.B. Pathogenesis ad immune mechanisms of chronic inflammatory bowel disease. Am. J. Gastroenterology. 1997; 92 (Suppl. 12): 533–589.
3. Scaldaferri F., Fiocchi C. Inflammatory bowel disease: Progress and current concepts of etiopathogenesis. J. Dig. Dis. 2007; 8: 171–178.
4. Papadakis K.A., Targan S.R. Role of cytokines in the pathogenesis of inflammatory bowel disease. Ann. Rev. Med. 2000; 51: 289–298.
5. Breese E., Michie C., Nicholls S. et al. Tumor necrosis factor alpha producing cells in the intestinal mucosa of children with inflammatory bowel disease. Gastroenterology. 1994; 106; 1455–1466.
6. Белоусова Е.А., Моисеев С.В. Инфликсимаб: 10 лет успешного применения при воспалительных заболеваниях кишечника. Клиническая фармакология и терапия. 2010; 19 (1): 50–54.
7. Targan S., Hanauer S., van Deventer S. et al. A short term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohns disease. N. Engl. J. Med. 1997; 337: 1029–1035.
8. Hanauer S., Feagan B., Lichtenstein G. et al. Maintenance infliximab for Crohns disease: the ACCENT I randomized trial. Lancet. 2002; 359 (9317): 1541–1549.
9. Bruce E., Sands M., Frank H. et al. Infliximab maintenance therapy for fistulizing Crohns disease. N. Engl. J. Med. 2004; 350: 876–885.
10. Hyams J., Crandall W., Kugathasan S. et al. Induction and maintenance infliximab therapy for the treatment of moderate to severe Crohns disease in children. Gastroenterology. 2006; 3.
11. Colombel J., Rutgeerts P., Reinisch W. et al. SONIC: A randomized, double-blind, controlled trial comparing infliximab and infliximab plus azathioprine to azathioprine in patients with Crohns disease naive to immunomodulators and biologic therapy. Gut. 2008; 57 (Suppl. II): 1.
Review
For citations:
Venediktova M., Tsimbalova E., Potapov А. CLINICAL EXAMPLES OF ANTICYTOKINE TREATMENT OF CHILDREN WITH CROHN DISEASE. Current Pediatrics. 2011;10(5):74–80.
Email this article 
